title: [Zidovudine efficacy and tolerance in 32 patients with cerebral toxoplasmosis in the acquired immunodeficiency syndrome].
authors.forename: C
authors.initials: C
authors.lastname: Leport
authors.forename: M
authors.initials: M
authors.lastname: Chakroun
authors.forename: S
authors.initials: S
authors.lastname: Matheron
authors.forename: W
authors.initials: W
authors.lastname: Rozenbaum
authors.forename: E
authors.initials: E
authors.lastname: Dournon
authors.forename: B
authors.initials: B
authors.lastname: Regnier
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D001927:Brain Diseases / Q000188:drug therapy*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D014123:Toxoplasmosis / Q000188:drug therapy*; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D015215:Zidovudine
vernacular_title: Efficacité et tolérance de la zidovudine chez 32 malades atteints de toxoplasmose cérébrale au cours du syndrome dímmunodéficit acquis.